Two Companies Seek Emergency Approval For Antibody Treatments | NBC Nightly News

President Trump touted an experimental antibody treatment as a cure for Covid-19. Now two companies have applied for emergency use authorization from the FDA. Critics, like NIH whistleblower Dr. Rick Bright, fear the process is being politicized.
» Subscribe to NBC News:
» Watch more NBC video:

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App:
Breaking News Alerts:
Visit NBCNews.Com:
Find NBC News on Facebook:
Follow NBC News on Twitter:
Follow NBC News on Instagram:

Two Companies Seek Emergency Approval For Antibody Treatments, NIH Whistleblower Urges Caution

Nightly News,Coronavirus,NBC Nightly News with Lester Holt,nbc news,news,breaking news,us news,world news,politics,current events,top stories,pop culture,business,health,nbc nightly news,lester holt,nbc news lester holt,nbc nightly news episode,nbc news full,nightly news full,Emergency Approval,Antibody Treatments,NIH Whistleblower Urges,NIH Whistleblower,President Trump,FDA,Dr Rick Bright,covid-19 news,antibody testing,coronavirus news,covid-19,